Projects
PERSIST
Funding: EU Horizon 2020
Be health PERSISTent, the future is in your hands
PERSIST can help especially to the health services like patient-reported outcomes, patient satisfaction scoring, identifying high-risk patients and giving them the appropriate treatment, and supporting patients who are either at high risk of reoccurrence.
RUBYnanomed will use the RUBYchip for the isolation of CTCs from a pool of patients of breast and colorectal cancer. These will be the objective markers for the patients included in the study, and highly complementary to the eHelath tools developed by the PERSIST partners. By combining the Big Data tools to be developed at PERSIST, plus the automation software to be developed by GRAD together with the biometric results, CTC counts and phenotypic classification, the project aims to provide a holistic solution to hospitals and clinicians.
Our Projects
Ongoing
BRIGHT EU
EIC Accelerator by European Innovation Council
Ongoing
BIOCELLPHE
EU Horizon 2020
Ongoing
HfPT – Health from Portugal
European Union-Next Generation UE
Finished
CTC-OncoDynamics
Caixa Impulse Consolidate by LA CAIXA Foundation
Finished
PERSIST
EU Horizon 2020
Finished
BRIGHT PT
AVISO 18 Norte 2020
Be health PERSISTent, the future is in your hands
PERSIST can help especially to the health services like patient-reported outcomes, patient satisfaction scoring, identifying high-risk patients and giving them the appropriate treatment, and supporting patients who are either at high risk of reoccurrence.
RUBYnanomed will use the RUBYchip for the isolation of CTCs from a pool of patients of breast and colorectal cancer. These will be the objective markers for the patients included in the study, and highly complementary to the eHelath tools developed by the PERSIST partners. By combining the Big Data tools to be developed at PERSIST, plus the automation software to be developed by GRAD together with the biometric results, CTC counts and phenotypic classification, the project aims to provide a holistic solution to hospitals and clinicians.